Member Info for Gordonbennett1

Sigh I should have sold too!!! back to where I started almost.

Once out it should ping, demand was strong on open!

Come on my son, don't turn now

Don’t miss the boat, it’s leaving and fast!

Busy start, BBC TV coverage, and a tiny float.

Tesla directors x3 on board!

17 m mcap is quite pitiful, suspect the value of the directors alone may be worth more than that. The would be if they were footballers that’s for sure

Moving hard now! Guess those early sells will be hurting later.

This really should be 0.5 plus now, the techs there and with legends in the game driving this, we are in for a ride!

Must be new highs from here! Yet to break by .24

Amen Bond! There’s a few ways it could play out here. 1, if HL know more than you and I and there is cash in the pot - great.

2, voted down, trading must resume and you would hope they are forced into seeking an RTO. Either way I’d hope the price won’t go much lower than pre suspension. Perhaps spike…

3, remain suspended post no vote, which to me would seem pretty unethical.

Big week ahead!!! Hope everyone has voted.

Big week ahead!!! Hope everyone has voted.

A lot but fantastic exposure in the US so should be well endowed

Exactly bojo! The revenue point is a red herring, companies at Angle stage are often valued on progress and probability of long term return. Watch the MCAP I think it will run away this week as the wider market grasp the potential value here. Revenues will come when the products are ready to roll out to the mass market.

Excellent summary Bermuda!

Some more informative posts this afternoon, posts without a negative agenda! I find it very peculiar a sp called LTH would knock his investment left right and centre. Look forward to a positive start to the week and possible news pre meeting.

Read the brokers notes from all parties and they are singing a different song, all up beat with very positive targets

Filter him best thing I’ve done in some time

Technical stuff indeed but because some may not fully understand does not mean that the investment case is any different. Those making the major calls know what the story is

Look forward to seeing a green tick in response to your comment Rocket, much rather that than read the I know better than you narrative.

This deserves to top the board now the long term hater has been filtered by the troops.

Financially, ANGLE appears to be on solid ground. Berenberg notes that costs and cash performed slightly ahead of expectations, extending the company's cash runway into the first quarter of 2025.

Jefferies echoes this sentiment, stating that prioritising resources could lead to around £5 million in cash savings by the end of 2024, further extending the cash runway.

In summary, ANGLE's liquid biopsy technology is showing promise in a nascent market.

While challenges remain, the company's strategic focus and financial prudence position it well for future growth.

Both Berenberg and Jefferies see a company on the cusp of tapping into a huge multi-billion-dollar market, making ANGLE a name to watch in the liquid biopsy space.

Filter him dealer, I have